Nephrotoxicity of amphotericin b in the treatment of cryptococcal meningitis in acquired immunodeficiency syndrome patients
View/ Open
Date
2009Author
Ochieng, PO
McLigeyo, SO
Amayo, EO
Kayima, JK
Omonge, EO
Type
ArticleLanguage
enMetadata
Show full item recordAbstract
Objectives: To describe the incidence of renal dysfunction, hypokalaemia and hypomagnesaemia in AIDS patients with cryptococcal meningitis and on amphotericin B treatment. Secondary objective was to determine all-cause mortality in the same group. Design: Prospective, observational study.
Setting: Kenyatta National Hospital (KNH), Nairobi, Kenya.
Subjects: Seventy consecutive patients with AIDS and cryptococcal meningitis on amphotericin B.
Results: About 58.6% of the patients had at least 100% rise in the creatinine level. Thirty eight point six per cent of patients experienced a rise in serum creatinine of at least 50%. Ninty three per cent of the patients developed hypokalaemia and 80% had hypomagnesaemia at trough magnesium level. Only 54.3% of patients completed the intended 14-day treatment. Thirty point five per cent of patients died within the two week follow-up period.
Conclussion: The incidences of amphotericin B associated nephrotoxicity, hypokalemia and hypomagnesaemia were high in this studied population.
URI
http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/10349http://www.ncbi.nlm.nih.gov/pubmed/21644414
Citation
East African Medical JournalPublisher
Department of Clinical Medicine and Therapeutics, College of Health Sciences, University of Nairobi
Collections
- Faculty of Health Sciences (FHS) [10377]